IBSENDA
Dead / Abandoned — Abandoned — no statement of use filed (as of 07 Mar 2016)
What this means for you
This application is over — abandoned 07 Mar 2016. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 86480995
- Mark type
- Stylized text
- Filed
- 15 Dec 2014
- Published for opposition
- 09 Jun 2015
- Abandoned
- 07 Mar 2016
- Attorney of record
- Matthew O. Brady
Goods and services
- Class 005 — Pharmaceuticals: Oral, Transdermal, Injectable and Intravaginal Contraceptives; Hormone replacement therapy preparations; Pharmaceutical preparations for the prevention of preterm birth or pregnancy; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations for the treatment and prevention of endometriosis; Pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; Iron chelating pharmaceutical preparations; Fertility enhancing preparations; Pharmaceuticals and medicines for the treatment and prevention of sexual dysfunction; Pharmaceuticals and medicines for the sensory organs; Pharmaceuticals and medicines for the central nervous system; Pharmaceuticals and medicines for the urogenital organs; Pharmaceuticals and medicines for the circulatory systems; Pharmaceuticals and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceuticals and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Antibiotics, Antifungals, Antivirals and Antiprotozoals; Pharmaceutical preparations for the prevention and treatment of bacterial infections; Pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression, neuroprotective agent; antidepressants; antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism
Owner
- FURIEX PHARMACEUTICALS, LLC, PARSIPPANY, NJ, US
- Furiex Pharmaceuticals, Inc., Parsippany, NJ, US
- Furiex Pharmaceuticals, Inc., Parsippany, NJ, US
Prosecution history
- 09 Mar 2016 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 07 Mar 2016 — ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
- 07 Mar 2016 — ABANDONMENT - NO USE STATEMENT FILED
- 04 Aug 2015 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 09 Jun 2015 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 09 Jun 2015 — PUBLISHED FOR OPPOSITION
- 20 May 2015 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 06 May 2015 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 06 May 2015 — ASSIGNED TO LIE
- 14 Apr 2015 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 08 Apr 2015 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Apr 2015 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 08 Apr 2015 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 27 Mar 2015 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 27 Mar 2015 — NON-FINAL ACTION E-MAILED